0 Комментарии
0 Поделились
551 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Late-Stage Oncology Drug Pipeline Market Research Report: Size, Share, Growth Factors, Trends & Forecast"Detailed Analysis of Executive Summary Late-Stage Oncology Drug Pipeline Market Market Size and Share The global late-stage oncology drug pipeline market size was valued at USD 10.85 billion in 2025 and is expected to reach USD 26.67 billion by 2033, at a CAGR of 11.90% during the forecast period Late-Stage Oncology Drug Pipeline Market Market research report is a...0 Комментарии 0 Поделились 522 Просмотры 0 предпросмотр
-
Late-Stage Oncology Drug Pipeline Market Share and Size Report: Emerging Trends and Forecast Analysis" According to the latest report published by Data Bridge Market Research, the Late-Stage Oncology Drug Pipeline Market The global late-stage oncology drug pipeline market size was valued at USD 10.85 billion in 2025 and is expected to reach USD 26.67 billion by 2033, at a CAGR of 11.90% during the forecast period A large scale Late-Stage Oncology Drug...0 Комментарии 0 Поделились 239 Просмотры 0 предпросмотр
-
Late-Stage Oncology Drug Pipeline Market Size, Share, Trends, Growth & Forecast Explained"Regional Overview of Executive Summary Late-Stage Oncology Drug Pipeline Market by Size and Share The global late-stage oncology drug pipeline market size was valued at USD 10.85 billion in 2025 and is expected to reach USD 26.67 billion by 2033, at a CAGR of 11.90% during the forecast period This Late-Stage Oncology Drug Pipeline report helps you to be there on...0 Комментарии 0 Поделились 411 Просмотры 0 предпросмотр
-
Precision Oncology Drug Portfolio market Forecast: Trends, Demand & Revenue Analysis"Precision Oncology Drug Portfolio Market Summary: According to the latest report published by Data Bridge Market Research, the Precision Oncology Drug Portfolio Market The global precision oncology drug portfolio market size was valued at USD 18.76 billion in 2025 and is expected to reach USD 45.46 billion by 2033, at a CAGR of 11.70% during the forecast...0 Комментарии 0 Поделились 459 Просмотры 0 предпросмотр
-
Taxane-Based Oncology Drug Class Market Dynamics: Trends and Forecast 2025 –2032Latest Insights on Executive Summary Taxane-Based Oncology Drug Class Market Share and Size CAGR Value The global taxane-based oncology drug class market size was valued at USD 7.21 billion in 2025 and is expected to reach USD 10.25 billion by 2033, at a CAGR of 4.50% during the forecast period The study and analysis conducted in this industry report...0 Комментарии 0 Поделились 288 Просмотры 0 предпросмотр
-
Taxane-Based Oncology Drug Class Market Dynamics: Trends and Forecast 2025 –2032According to the latest report published by Data Bridge Market Research, the Taxane-Based Oncology Drug Class Market CAGR Value The global taxane-based oncology drug class market size was valued at USD 7.21 billion in 2025 and is expected to reach USD 10.25 billion by 2033, at a CAGR of 4.50% during the forecast period Global Taxane-Based...0 Комментарии 0 Поделились 172 Просмотры 0 предпросмотр
-
Taxane-Based Oncology Drug Class Market Overview: Key Drivers and Challenges 2025 –2032Executive Summary Taxane-Based Oncology Drug Class Market Market: Growth Trends and Share Breakdown CAGR Value The global taxane-based oncology drug class market size was valued at USD 7.21 billion in 2025 and is expected to reach USD 10.25 billion by 2033, at a CAGR of 4.50% during the forecast period This global Taxane-Based Oncology Drug Class Market...0 Комментарии 0 Поделились 345 Просмотры 0 предпросмотр
-
(R)-N-Boc-3-(Aminomethyl)Pyrrolidine Market 2026–2034: Chiral Pharmaceutical Intermediates Driving CNS, Oncology, and Antiviral Drug Development(R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period. (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....0 Комментарии 0 Поделились 571 Просмотры 0 предпросмотр
-
Anal Cancer Drug Market: Chemotherapy, Targeted Therapies, and Immunotherapy Treatment Strategies in Oncology"Executive Summary Anal Cancer Drug Market Research: Share and Size Intelligence The global anal cancer drug market size was valued at USD 401.57 million in 2024 and is projected to reach USD 1,199.82 million by 2032, with a CAGR of 13.80 % during the forecast period of 2025 to 2032. Best-practice models and research methodologies have been employed in the reliable Anal Cancer Drug Market...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Anti-Oral Mucositis Drug Market Trends Shaping Oncology Supportive Care in 2026Oral mucositis is a painful inflammatory condition affecting the mucous membranes inside the mouth, often experienced by cancer patients undergoing aggressive treatment procedures. Anti-oral mucositis drugs help reduce inflammation, pain, ulcer formation, and infection risks while improving patient comfort and treatment adherence. Growing investments in oncology supportive care and innovative...0 Комментарии 0 Поделились 665 Просмотры 0 предпросмотр
-
Antibody-Drug Conjugate (ADC) Oncology Market Overview: Key Drivers and ChallengesRegional Overview of Executive Summary Antibody-Drug Conjugate (ADC) Oncology Market by Size and Share CAGR Value The global Antibody-Drug Conjugate (ADC) oncology market size was valued at USD 1.28 billion in 2025 and is expected to reach USD 2.91 billion by 2033, at a CAGR of 10.80% during the forecast period The strategies encompassed in the...0 Комментарии 0 Поделились 271 Просмотры 0 предпросмотр
-
Dasatinib Market Growth in Emerging Healthcare MarketsThe global Dasatinib Market was valued at USD 5.6 billion in 2025 and is projected to reach USD 7.6 billion by 2033, expanding at a CAGR of 4.3% from 2026 to 2033. The market is witnessing steady growth due to the increasing prevalence of hematologic cancers, particularly Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)....0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Advanced Therapeutics and Precision Medicine Fuel Expansion of the High Potent Pharmaceuticals Product Market 2031The high potent pharmaceuticals product market is witnessing strong global momentum as the healthcare industry increasingly shifts toward targeted therapies and precision-based treatments. These pharmaceutical products are characterized by their ability to deliver highly effective therapeutic outcomes at very low doses, making them essential in treating complex diseases such as cancer, hormonal...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Blood Cancer Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Blood Cancer Market Global blood cancer market size was valued at USD 57.23 billion in 2024 and is projected to reach USD 117.43 billion by 2032, with a CAGR of 9.40% during the forecast period of 2025 to 2032. With the effectual use of technology, innovative applications and expertise, Blood Cancer...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Breast Cancer Drugs Market Size and Revenue Forecast to 2030According to the latest report published by Data Bridge Market Research, the Breast Cancer Drugs Market Data Bridge Market Research analyzes that the global breast cancer drugs market is expected to reach USD 55,996.57 million by 2030 from USD 30,247.54 million in 2022, growing at a CAGR of 8.2% during the forecast period of 2023 to 2030. All the statistical data including...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Circular RNA Therapeutics Market Size, Industry Trends, and Growth Forecast to 2033According to the latest report published by Data Bridge Market Research, the Circular RNA Therapeutics Market The global Circular RNA Therapeutics market size was valued at USD 784 Million in 2025 and is expected to reach USD 4188.13 Million by 2033, at a CAGR of 23.30% during the forecast period To impart a supreme quality to this persuasive Circular RNA...0 Комментарии 0 Поделились 11Кб Просмотры 0 предпросмотр
-
Cytotoxic Drugs Market Size, Share, Trends & Forecast to 2032According to the latest report published by Data Bridge Market Research, the Cytotoxic Drugs Market Global cytotoxic drugs market size was valued at USD 17.59 billion in 2024 and is projected to reach USD 42.11 billion by 2032, with a CAGR of 7.5% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate,...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Generic Oncology Drug Market – Complex Generics and Targeted Therapy AccessMarket Overview The generic oncology drug market is advancing into complex generics for targeted therapies including kinase inhibitors, immunomodulatory drugs, and nanomedicine formulations that present formulation and bioequivalence challenges beyond traditional small molecules. As patents expire on oral targeted agents that have transformed cancer outcomes, complex generic development is...0 Комментарии 0 Поделились 95 Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek
Bengali